In addition of proven track record of achievements in business, I also had a successful scientific career. This rare blend of technology, bioscience and business skills is well suited to help commercial organisations to build vision, develop a growth strategy and drive the commercial execution.
Scientific publications in peer-reviewed international journals
Biochem Pharmacol. 2001 Apr 15;61(8):965-78.
Stimulation of cyclooxygenase-2-activity by nitric oxide-derived species in rat chondrocyte: lack of contribution to loss of cartilage anabolism.
Life Sci. 2000;67(2):185-96.
Nonsteroidal anti-inflammatory drugs and phenols glucuronidation in Caco-2 cells: identification of the UDP-glucuronosyltransferases UGT1A6, 1A3 and 2B7.
Arthritis Rheum. 1999 Oct;42(10):2094-102.
Cartilage protection by nitric oxide synthase inhibitors after intraarticular injection of interleukin-1beta in rats.
Arthritis Rheum. 1999 Sep;42(9):1951-60.
Evidence for neurogenic transmission inducing degenerative cartilage damage distant from local inflammation.
Arch Biochem Biophys. 1998 Oct 1;358(1):63-7.
Identification of the uridine diphosphate glucuronosyltransferase isoform UGT1A6 in rat brain and in primary cultures of neurons and astrocytes.
Life Sci. 1997;60(22):1943-51.
Expression and inducibility of UDP-glucuronosyltransferases 1-naphthol in human cultured hepatocytes and hepatocarcinoma cell lines.
Cell Biol Toxicol. 1996 Apr;12(2):115-23.
Inducibility of ethoxyresorufin deethylase and UDP-glucuronosyltransferase activities in two human hepatocarcinoma cell lines KYN-2 and Mz-Hep-1.
Biochem Pharmacol. 1995 Aug 8;50(4):557-61.
Glucuronidation in the Caco-2 human intestinal cell line: induction of UDP-glucuronosyltransferase 1*6.
Cell Biol Toxicol. 1995 Aug;11(3-4):179-85.